Navigation Links
Sysmex America Earns Spot on Top 100 Best Places to Work in Healthcare
Date:12/1/2011

MUNDELEIN, Ill., Dec. 1, 2011  /PRNewswire/ -- Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, today announces that the company has been named as one of Modern Healthcare's Top 100 Best Places to Work in Healthcare, ranking at #38 for companies in equal size and #66 overall.  Results were based on company application and employee survey results representing 25% and 75% of the scoring respectively.  This award, which marks Sysmex America's first appearance on Modern Healthcare's Top 100 Best Places to Work list, follows the company's third Center for Companies That Care Honor Roll award in March which also recognizes Sysmex America's outstanding workplace practices.

"Sysmex America is honored to be among Modern Healthcare's Top 100 Best Places to Work.  It is an award that further validates our company's efforts to ensure our employer programs support employee work-life balance, educational and career goals and job satisfaction. By enabling our employees to work at an optimum level, we make it possible for them to provide our customers with best-in-class products and services that make a real difference in clinical and operational results in clinical laboratories worldwide," said Karen Stoneman, Vice President of Human Resources, Sysmex America, Inc. 

Modern Healthcare conducted its program to recognize outstanding employers in the healthcare industry on a national level.  The program, administered by the Best Companies Group, a PA-based firm that administers "best places to work" programs nationwide, conducted two surveys of healthcare organizations and companies that volunteered to participate. The first survey was a questionnaire for a participating employer detailing company policies, practices, benefits and demographics.

The second survey was a satisfaction survey of a participating compa
'/>"/>

SOURCE Sysmex America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OhioHealth Installs Newest Version of Sysmexs Hematology Middleware, Sysmex WAM(TM) 4.0
2. Sysmex America Adds Industry Veteran to Company Leadership
3. Sysmex America Honored Second Consecutive Year as a Company That Cares
4. Sysmex America Announces Executive Leadership Changes
5. Sysmex America Announces Amerinet Urinalysis Contract
6. Sysmex America Begins Distribution of CellaVision® DM1200
7. Sysmex America and Medica Corporation Announce Distribution Partnership
8. Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
9. Sysmex America Awarded National Novation GPO Contract for Automated Urinalysis
10. Sysmex America Announces LabCorp Hematology Automation Agreement
11. Sysmex America Announces Amerinet Hematology Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 NxStage Medical, Inc. (Nasdaq: NXTM ... reported first quarter financial results that exceed the top ... for the first quarter of 2015 increased 10 percent ... for the first quarter of 2014. The Company,s revenue ... to $78.5 million.  The increase was driven by outperformance ...
(Date:5/6/2015)... N.J. , May 6, 2015  IGI Laboratories, Inc. ... specialty generic pharmaceutical company, will be presenting today at the ... take place on May 6 th and 7 th ... Jason Grenfell-Gardner , CEO and President ... Laboratories, Inc., will present today, May 6, 2015, at 3:30 p.m. ET. ...
(Date:5/6/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("Juniper" ... three-month period ended March 31, 2015. First quarter financial highlights ... increase of 19% as compared to $7.0 million in ... increased 41% year-over-year, enabled by the return of normalized ... in the fourth quarter of 2014; , Service ...
Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... urges psoriasis patients to take control,of their health, help ... A study released,this week showing that people with ... should prompt them to take steps to improve their,overall ... study -- published in the Archives of Dermatology and ...
... Holdings, Inc. (OTC Bulletin Board: LIXT) a developer ... cancer, announced the,closing of a private placement. In ... Stock at a price of $0.65 per share ... acted as placement agent and,received $65,000 in commissions ...
Cached Medicine Technology:Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action 2Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action 3Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement 2Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement 3
(Date:5/6/2015)... Mesa, Arizona (PRWEB) May 6, ... Ventures, Inc. (MAV), an investor backed Colorado cannabis ... based Phoenician Engineering subsidiary three times since first ... achieved profitability from operations, within one year of ... the end of 2014 to over 500 today ...
(Date:5/6/2015)... The American Water Resources Association (AWRA) announces ... Integrated Water Resources Management (IWRM) award , recognizing excellence in ... , An IWRM approach to water resources has been a ... 12 projects were nominated for the award. The May issue ... 2014 AWRA IWRM Award winner - One Water, One Watershed ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 Doctors ... recently reported what they are calling “unprecedented” tumor control ... article on the new research. Click here to ... gave pembrolizumab to 25 mesothelioma patients between March and ... meeting in April. , “Pembrolizumab… provides robust antitumor activity ...
(Date:5/6/2015)... May 06, 2015 ProTrailer Cartoon Volume ... self-animating generators for Final Cut Pro X . ... titles to a Final Cut Pro X project.It includes ... quality openers to any shot has never been easier. ... in mind, saving users time while adding amazing openers ...
(Date:5/6/2015)... Omaha, NE (PRWEB) May 06, 2015 The ... to a nationwide nursing shortage to an increase in educational ... Aureus Medical Group , offers insight on these trends ... most of the multitude of opportunities that exist in the ... , Widespread electronic health record implementation has been prevalent across ...
Breaking Medicine News(10 mins):Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 3Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 4
... by Regulatory Approval of Once-Daily Tramadol in, ... for Depression -,LAVAL, QC, Feb. 26 /PRNewswire-FirstCall/ - Labopharm Inc. ... results for the fourth quarter and year ended December 31, ... , "With our first product about to be rolled out ...
... global rare disease community to raise awareness for underserved ... Feb. 26 Shire Human Genetic Therapies (HGT), a ... company, today announced it will join together with the ... Rare Disease Day on February 28, 2009. The purpose ...
... ST. LOUIS, Feb. 26 Stereotaxis, Inc.,(Nasdaq: ... fourth quarter,ended December 31, 2008. Revenue for the ... 18% over the fourth quarter of 2007. Stereotaxis,recognized ... systems in the quarter. Revenue from sales of ...
... 26 MIND Research Institute today,announced that Jim Mazzo, ... was recently elected to MIND,s board of directors. Mr.,Mazzo ... numerous boards and,committees at the University of California ... of Trustees, the Engineering Advisory Board Committee, and,the Eye ...
... Prestigious AwardsLONDON, Feb. 26 The Healthcare ... Frost & Sullivan,s ,Excellence in Healthcare Awards ... London Zoo, London. The industry,s most influential ... their achievements during an evening dinner gala.(Logo: ...
... Footwear by BeechHUNTINGTON BEACH, Calif., Feb. 26 ... Originals line with new adjustable toe separators ... foot therapy can now be customized to fit ... increasing flexibility and helping improve balance and body ...
Cached Medicine News:Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 2Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 3Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 4Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 5Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 6Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 7Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 8Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 9Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 10Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 11Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 12Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 13Health News:Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008 14Health News:Shire Celebrates World Rare Disease Day on February 28 2Health News:Shire Celebrates World Rare Disease Day on February 28 3Health News:Shire Celebrates World Rare Disease Day on February 28 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 2Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 3Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 4Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 5Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 6Health News:Stereotaxis Reports Fourth Quarter 2008 Financial Results 7Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Frost & Sullivan Awards to Celebrate Healthcare Excellence 2Health News:Sandal Evolution(R) Takes a Healthy Step 2
... surgeons with brighter, crisper, magnified views of ... many minimally invasive spine procedures. It is ... of contact. The first graphical touchscreen to ... intuitive user guidance similar to that known ...
Micro Dissecting Curette, 5 1/2", Round....
14 cm, very delicate, round cupped jaws, straight jaws, 3.0 mm...
Wilson pituitary forcep, flattened tip, 3 mm bite, 145 mm effective....
Medicine Products: